This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A whitepaper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month.
The recommendations for the Country’s pathway towards DTx are captured in the WhitePaper “Digital Therapeutics, an Opportunity for Italy” The official journal of the Smith Kline Foundation, Tendenze Nuove , published the WhitePaper “ Digital Therapeutics, an Opportunity for Italy ” on 13 January 2021.
A new focus on “place” and the introduction of medicines registers are among the proposals in a new government whitepaper on the future of NHS England. One surprise within the whitepaper was the introduction of the concept of medicines registries, says Thorne. “In Opportunities abound.
To learn more about how the 3M Harvest RC Chromatographic Clarifier is revolutionising biopharma production, download this specially commissioned whitepaper. “This can result in reductions in costs for our customers.”
In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases. This document delved into aspects related to manufacturing, preclinical, and clinical trial design for all phases of clinical development.
“The industry has concerns regarding the use of regulatory tools designed for medicines authorisation being applied to address availability issues that are within the remit of member states,” says the whitepaper. . — EFPIA (@EFPIA) April 11, 2022.
To enable this, the design documentation, whitepaper and testing results have been made available open source to all, 6 with the hope that we will see this technology become the standard for buffer preparation as we look to create further efficiencies in the future. . References. cited 2022Nov] Available from: [link].
Preamble Why this WhitePaper? A whitepaper (sometimes called as whitepaper) is an information document issued by an organization to highlight the solution to a problem the functionality of a solution, good, or service.
To learn more about the 3M TM Harvest RC Chromatographic Clarifier and the efficiencies achievable in biopharma manufacturing, download the specially commissioned whitepaper on this page.
To learn more about the ways that the 3MTM Harvest RC Chromatographic Clarifier can increase efficiencies in the production of mAb therapies, download this specially commissioned whitepaper.
While I was able to keep all documentation on Canvas, I had to constantly check submissions, which took a significant amount of time. 2021-22 American Association of Colleges of Pharmacy Competency-Based Education Joint Task Force WhitePaper. References Competency-based education task force. Posted August 8, 2022.
The NHC strives to share relevant policy work such as comment letters, working documents on policy positions, and whitepapers with its members well ahead of deadlines. The NHC also provides access to deep policy resources and expertise on a broad range of complex issues that impact all people with chronic conditions.
Furthermore, initiatives aimed to enhance knowledge sharing through publishing whitepapers, guidelines and research reports as well as providing network opportunities to foster dialogue between the industry and regulators assure that the industry remains informed. References [link] [link] 281%29.pdf
Documenting the change in pharma’s engagement of HCPs is one thing – predicting where channel mix goes in the future, the most important question, is quite another. The UK is also unique compared to other countries as remote detailing has risen and continues at close to peak levels.
Unlike many of its predecessors, then, this document is not merely an exercise in raising awareness. BIVDA really hope that the whitepaper will help inform UK policy makers and give them areas to focus on which we, as a coalition, see as critical to start moving this issue forward.”. Clear objectives.
QbD principles are woven into regulatory guidance documents, primarily guidances Q8 to Q11 of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). For more information on this, please download our whitepaper. For more information, please download our whitepaper.
In 2021, the CDC documented a sharp rise in HAIs, which prior to the pandemic had been steadily decreasing. In March of 2022, APIC published a call-to-action whitepaper , exploring the lessons learned by IPs during COVID and highlighting the actions necessary at the facility level and the U.S.
As I’ve discussed before on this blog, counterfeit products DO exist and even have the apparently appropriate T3 documents to validate their legitimacy. For example, there’s this whitepaper by Cardinal Health’s CTO last year claiming that blockchain is the solution to all of the supply chain’s problems.
The NHC also requests that CMS highlight when and how the agency removed QALY-based metrics from consideration in MFP justification documentation. Therefore, the NHC requests that CMS offer more clarity into exactly how it will exclude QALY-based metrics from analysis of certain evidence in value-based decisions.
And regulating LDTs through guidance documents is vulnerable to legal challenge on procedural grounds. See , e.g. , ACLA WhitePaper on LDTs here. Rulemaking avoids the twin problems of dependency on action by Congress and the legal weakness of imposing substantive legal requirements through guidance.
15 The NHC advocates for rigorous, transparent documentation of the medical rationale in such instances to prevent discriminatory practices. Traditional value assessment methods fail communities of color and exacerbate health inequities whitepaper. nmqf.org/s/Disparities-and-Value-Assesssment-White-Paper.pdf 17 Stoumpos, A.,
According to the legal documents , the plaintiffs accused the companies of “violating federal antitrust laws, alleging “per se” and “rule of reason” violations”. Gilenya is an oral medication for multiple sclerosis.
To find out more about Pall’s specialist filters and the services available in water safety, download the whitepaper on this page. This document will explain the dangers associated with waterborne bacteria and the importance of a Holistic Water Safety Plan.
To learn more, download the document below. model, download this whitepaper. Through its Maggie family of autoinjectors, SHL is working with its partners to advance the device development side of combination products, together gaining key competitive edges in this burgeoning subcutaneous drug delivery market. References 1.
The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.
In addition, several pieces of documentation will be required to support the API qualification, e.g. pharmacopeial compliance. It is also essential to evaluate the reliability of the company supplying the ingredient: do they provide sufficient communication and documentation?
Integrated logistics and quality data is documented automatically, and operators can spend less time chasing status, progress and performance data from multiple sources. Effective data sharing can enable the automation of quality documentation, release processes and stability budgets. Challenge 3: Minimising waste.
Fast-forward to March 2023, when The White House OSTP issued a document per Executive Order 14081, titled “ Bold Goals for U.S. Biotechnology and Biomanufacturing; Harnessing Research and Development to Further Societal Goals.”
To learn more about the development and partnership opportunities for businesses within Scotland’s health sector, download the document on this page. Free Whitepaper. Precision Medicine: Streamlining Treatments and Drug Development.
This comprehensive resource provides a detailed calendar of key healthcare conferences happening across the US and Europe in 2025, all in a single, easy-to-access document. Whats inside?
While not binding, the document covers the regulatory and scientific considerations needed for the development and implementation of continuous manufacturing in pharma, and the guidelines are meant for both new and pre-existing products. Funding was also given to companies that would bolster US-based production of critical medicines.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content